Global Head, Science, Technology, and Innovation, Science Innovations, LLC; Adjunct Associate Professor, Case Western Reserve University, School of Engineering and Weatherhead School of Management
Dr. Michael Hill is a global-minded, skilled entrepreneur and authentic leader creating meaningful, patient-inspired, medical device technology innovations from idea/discovery to commercial scale. He has deep domain knowledge of science and technology and experience with research, product development and clinical research/regulatory. He is adept in successfully leading large global, diverse organizations and high performing teams. He has a thorough understanding of the fundamentals related to global healthcare systems to deliver impactful transformative innovations. He is curious, passionate and
perseveres toward creating the future.
He joined Medtronic in July 1992 as a Scientist in the Cardiac Rhythm Management division of Medtronic in Minneapolis, MN, working on arrhythmia prevention research. In 1998, Dr. Hill became a Senior Scientist and Technical Fellow in the Heart Failure division of Medtronic and led the research efforts on the novel therapy of cardiac resynchronization therapy. In 2001 he became a Bakken Fellow and Principle Clinical Program manager leading the effort on ambulatory hemodynamic monitoring and became Director of Clinical, Heart Failure New Therapies in 2003. In 2004, Dr. Hill became the Director of Clinical Research at the Bakken Research Center in the Netherlands responsible for Cardiac Rhythm Disease Management research, clinical outcome trials and health economic outcomes in Europe, Middle East and Africa. He returned to Minneapolis in 2007 as Medtronic’s Senior Director of Programs in New Therapies and Diagnostics, CRDM where he had program management responsibilities for novel therapy and diagnostic opportunities in chronic cardiac diseases. In 2012 he became Vice President of Research and Development of the Heart Failure Business Unit. In May 2016, Michael became the Vice President of Corporate Science, Technology, and Clinical Affairs, inspiring and enabling the enterprise-wide technical community to create patient-inspired, meaningful innovations. In September of 2018, Michael became the Vice President of Corporate Science & Technology and Innovation to focus on building a sustainable innovation ecosystem for Medtronic’s continued and future success. Michael retired from Medtronic in 2019 after 27 successful years of continuously bringing significant innovations to scale. He supports educational programs for science, technology, engineering and diversity & inclusion; and remains active in knowledge sharing, creating intersections, improving decision-making, and accelerating the cycle of innovation.
In 2010, Dr. Hill achieved a significant milestone obtaining his fiftieth patent in his 18 years with Medtronic; he now holds more than sixty. Dr. Hill has authored several book chapters, manuscripts, and abstracts. He is a reviewer for several medical journals and is often an invited lecturer at international healthcare and innovation conferences. He was awarded a
is a global-minded, skilled entrepreneur and authentic leader creating meaningful, patient-inspired, medical device technology innovations from idea/discovery to commercial scale. He has deep domain knowledge of science and technology and experience with research, product development and clinical research/regulatory. He is adept in successfully leading large global, diverse organizations and high performing teams. He has a thorough understanding of the fundamentals related to global healthcare systems to deliver impactful transformative innovations. He is curious, passionate and perseveres toward creating the future. CRDM Star of Excellence award in 2011. In 2012, he was inducted as Fellow of the American Institute of Medical and Biological Engineering. In 2013, he was awarded the Distinguished Engineering Alumni award from Duke University. He was awarded the Medtronic Patent of Distinction Award in 2014. In 2020, he was awarded the Wallace H. Coulter Award for Healthcare Innovation, recognizing an outstanding individual who has demonstrated a lifetime commitment to and made important contributions to patient healthcare, from the Biomedical Engineering Society and Wallace H. Coulter Foundation. Dr. Hill has been a member of the American Heart Association since 1992; served on the Board of Directors of the Greater Minneapolis AHA chapter (1998 – 2005); and served as President of the Board (2003-4). He was a member of the Northland Affiliate AHA Research Committee (2001-2004) reviewing cardiovascular research grant and fellowship applications. He was awarded the AHA Research Achievement Award (Northland Affiliate) in 2002. He is member of IEEE, BMES, HRS, HFSA, and ACRP.
Dr. Hill served on the Coulter Foundation committee at Duke University (2014-2019); Steering Committee of LIRYC Institute, Bordeaux University (2014-2019) and the Technical and Leadership Advisory Committees to the American Regenerative Manufacturing Institute (2017-2019). Since 2015, he serves on the Corporate Executive Committee at Case Western Reserve University.
A native of Jackson, Tennessee, Dr. Hill received his BSE [Biomedical and Electrical Engineering] and BS [Mathematics] Degrees from Duke University, MS and PhD [Biomedical Engineering] Degrees from Case Western Reserve University, and MBA [Management] Degree from the University of St. Thomas.
Dr. Hill enjoys traveling, food and cultures, skiing and scuba diving, storytelling, and enjoying his homes in San Diego, CA; Dania Beach, FL and Barcelona, ES.